Researchers with the Myeloma Institute at the University of Arkansas for Medical Sciences (UAMS) have identified one reason myeloma patients respond differently to treatment — the cancer cells can vary in type and intensity, depending on where they are located in the bone marrow.
The team, headed by Leo Rasche, MD, and Niels Weinhold, PhD, reported these findings in the Aug. 16 edition of the online publication Nature Communications in the article, “Spatial Genomic Heterogeneity in Multiple Myeloma Revealed by Multi-region Sequencing.”

Pao-Feng Tsai, PhD, RN, professor in the University of Arkansas for Medical Sciences (UAMS) College of Nursing and Sarah Rhoads, PhD, APRN, director of education in the UAMS Center for Distance Health, were inducted on Oct. 7 as Fellows of the American Academy of Nursing.